| Authors: |
Fassl A; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA 02215.; Department of Urology, Goethe University Frankfurt, University Hospital, Frankfurt am Main 60596, Germany.; Frankfurt Cancer Institute, Frankfurt am Main 60596, Germany.; German Cancer Consortium, Partner Site Frankfurt/Mainz, Frankfurt am Main 60596, Germany., Palacios Espinoza M; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA 02215., Butter D; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA 02215., Kolodziejczyk A; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA 02215., Seehawer M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Medicine, Harvard Medical School, Boston, MA 02215., Hill C; Boston Children's Hospital, Department of Pediatrics, Harvard Medical School, Boston, MA 02215., Ning X; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Immunology, Harvard Medical School, Boston, MA 02215., Branigan TB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Medicine, Harvard Medical School, Boston, MA 02215., Peñailillo J; Department of Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215., Saengboonmee C; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA 02215.; Department of Biochemistry, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand., Jadhav H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Medicine, Harvard Medical School, Boston, MA 02215., Charbonnier LM; Boston Children's Hospital, Department of Pediatrics, Harvard Medical School, Boston, MA 02215., Waks AG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Medicine, Harvard Medical School, Boston, MA 02215., Strawser C; Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC 27710., McDonnell DP; Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC 27710., Shapiro GI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Medicine, Harvard Medical School, Boston, MA 02215., Tolaney SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Medicine, Harvard Medical School, Boston, MA 02215., Polyak K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Medicine, Harvard Medical School, Boston, MA 02215., Sammons S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Medicine, Harvard Medical School, Boston, MA 02215., Wucherpfennig KW; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Immunology, Harvard Medical School, Boston, MA 02215., Sicinski P; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA 02215.; Department of Histology and Embryology, Medical University of Warsaw, Warsaw 02-004, Poland. |
